New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 11, 2013
06:25 EDTSIALSigma-Aldrich downgraded to Sell from Neutral at UBS
UBS downgraded Sigma-Aldrich due to rich valuation and relative growth outlook. Price target lowered to $70 from $76.
News For SIAL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 28, 2015
07:02 EDTSIALSigma-Aldrich and Merck GaA 'making progress' toward completing acquisition
Sigma-Aldrich (SIAL) announced it is making progress toward closing the planned acquisition of the Company by Merck KGaA (MKGAY), Darmstadt, Germany. The closing is now expected within the next two months. On August 11, 2015, Sigma-Aldrich and Merck announced they had obtained all necessary antitrust approvals, with the approval of the European Commission (EC) being conditional upon the sale of parts of Sigma-Aldrich's solvents and inorganics business in Europe. Negotiations with potential buyers are in the final stage. Once a binding agreement has been signed, the EC must approve the buyer before Merck can complete the Sigma-Aldrich acquisition. On September 22, 2014, Merck and Sigma-Aldrich announced they had entered into a definitive agreement under which Merck, will acquire Sigma-Aldrich for $17 billion - $140 cash per share, establishing one of the leading players in the $130 billion global life science industry.
September 25, 2015
07:33 EDTSIALGlobal Interdependence Center to co-host a discussion
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use